Conversely, depletion of NUB1 in conjunction with low ER levels appeared to exacerbate recurrence in BC patients, while higher NUB1 expression coupled with high ER levels may serve as a protective factor against recurrence (Figure 3E). Here, NUB1 is linked to breast cancer.